Abstract

The review summarizes the results of our own studies and published data on the biological markers of psychiatric disorders, with special emphasis on the activity of platelet monoamine oxidase. Pharmacotherapy studies in patients with the mixed anxiety-depressive disorder and first episode of schizophrenia have shown that the activity of platelet monoamine oxidase could serve as a potential biomarker of the efficacy of therapeutic interventions in these diseases.

中文翻译：

---

单胺氧化酶作为精神疾病治疗功效的潜在生物标志物

摘要

该综述总结了我们自己的研究结果和已发表的关于精神疾病生物标志物的数据，特别强调了血小板单胺氧化酶的活性。对混合性焦虑抑郁症和精神分裂症首次发作的患者的药物治疗研究表明，血小板单胺氧化酶的活性可以作为这些疾病治疗干预效果的潜在生物标志物。